Pay in 4 interest-free payments of $6.64 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Actual selection of meals in the plan is subject to change
Standard FDA-approved dosing escalation The FDA-approved tirzepatide dosing schedule, used in the SURMOUNT and SURPASS clinical trials, follows this pattern: Weeks 1 to 4: 2.5 mg once weekly (starting dose) Weeks 5 to 8: 5 mg once weekly Weeks 9 to 12: 7.5 mg once weekly (optional increase) Weeks 13 to 16: 10 mg once weekly (optional increase) Weeks 17 to 20: 12.5 mg once weekly (optional increase) Week 21 and beyond: 15 mg once weekly (maximum dose) Each dose increase happens after a minimum of four weeks at the current dose
If you experience any suspected side effects from your GLP-1 medication, you can report these through the MHRA Yellow Card Scheme
iHealth Track Smart Upper Arm Blood Pressure Monitor iHealths innovative blood pressure monitor records up to 99 readings on the device itself and the rest through an app to help you track trends over the course of weeks, months and years
This ratio worsens considerably when caloric surplus exceeds 300-500 calories above maintenance
Stops Glucagon : GLP-1 inhibits glucagon, a hormone that raises blood sugar, helping to prevent spikes
